The merger is set to create a global coatings giant that is expected to generate $17 billion in annual revenue.

I rate Pagaya Technologies Ltd. a Strong Buy as it emerges as a leading AI-driven lending infrastructure provider for banks and fintechs. PGY acts as a 'picks and shovels' supplier, enabling lenders to automate underwriting, expand credit, and reach new borrower segments efficiently. Q3 2025 results highlight PGY's momentum: record revenue, profit, expanding margins, and a 19% year-over-year increase in network volume to $2.8 billion.

XP Inc. ( XP ) Q3 2025 Earnings Call November 17, 2025 5:00 PM EST Company Participants Andre Parize - Chief Investor Relations Officer Thiago Maffra - Chief Executive Officer Victor Mansur - Chief Financial Officer Conference Call Participants Eduardo Rosman - Banco BTG Pactual S.A., Research Division Yuri Fernandes - JPMorgan Chase & Co, Research Division Mario Pierry - BofA Securities, Research Division Gustavo Schroden - Citigroup Inc., Research Division Daniel Vaz - J.

ING Bank Śląski takes full control of Goldman Sachs TFI by acquiring remaining 55% stake ING announced today that ING Bank Śląski has reached an agreement with Goldman Sachs on the full acquisition of the Polish asset management company Goldman Sachs TFI. ING already owns 45% of the company and with acquiring the remaining 55% stake it brings its ownership to 100%.

SINGAPORE--(BUSINESS WIRE)--BW LPG Limited (“BW LPG”, the “Company”, OSE ticker code: “BWLPG.OL”, NYSE ticker code: “BWLP”), the owner and operator of the world's largest fleet of Very Large Gas Carriers (VLGCs), announces today that it will release its Q3 2025 Financial Report at approximately 07:00hrs CET/ 01:00hrs EST/ 14:00hrs SGT on 2 December 2025. In connection with this release, BW LPG will hold an Earnings Presentation with Kristian Sørensen (CEO) and Samantha Xu (CFO). The details are.

VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics today announced the appointment of Scott Platshon as Acting Chief Investment Officer.

Creates a global coatings leader with $17 billion in revenue and an enterprise value of $25 billion Significant value creation with approximately $600 million in cost synergies supporting strategic and capital allocation priorities Combines highly complementary portfolios across end markets, driving stronger revenue growth, enhanced profitability and increased value for customers Expands geographic reach, brings together world-class technology and innovation platforms and offers a full spectrum of solutions to deliver exceptional value to customers Highly attractive financial profile featuring strong EBITDA margins and robust cash flow generation One ‑ tier Board to be led by current Axalta Chair Rakesh Sachdev …

VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME) a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced a novel strategic initiative focused on optimizing future cash flows from Ziihera® (zanidatamab-hrii), other licensed products and other healthcare assets. Together with the ability to leverage existing and future R&D partnerships and collaborations through internal innovation, this strategy seeks to optimize a long-term source of growing revenue streams with carefully managed R&D investments to establish a durable, profitable operating structure.

Look Forward: Unlocking Africa brings together S&P Global research on the continent's economic outlook Report highlights how renewable energy, sustainable and blended finance, capital market development, and infrastructure investment are shaping Africa's future JOHANNESBURG , Nov. 18, 2025 /PRNewswire/ -- Africa's abundant natural resources, young population and expanding middle class are set to redefine the continent's role in global economic growth, sustainable development and the energy transition, S&P Global said in its latest Look Forward Journal. Look Forward: Unlocking Africa brings together S&P Global research on the continent's economic outlook, highlighting how renewable energy, sustainable and blended finance, capital market …

The airline is launching service to La Crosse, Wis., Trenton, N.J.

Freshworks Inc. delivered a strong Q3, beating revenue and EPS estimates, and raised full-year guidance, reinforcing its position in my portfolio. FRSH is successfully moving upstream, winning larger contracts, and leveraging AI-driven products, like Freddy Copilot, to drive customer spend and retention. Despite high stock-based compensation impacting GAAP profitability, SBC is declining, and strong cash flows support potential new share buybacks.

OPEC's Secretary General pushes back against reports of a looming global oil surplus in 2026 in an interview with CNBC's Dan Murphy.

Honda Motor said it will begin gradually resuming normal operations at its North American vehicle assembly plants from Monday, a sign that production disruptions from a shortage of Nexperia chips are easing.

SAN DIEGO , Nov. 18, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Skye Bioscience, Inc. (NYSE: FCX) securities between November 4, 2024 and October 3, 2025. Skye is a clinical stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled receptors ("GPCRs") to treat obesity, overweight, and metabolic diseases.

MoonLake Immunotherapeutics is rated Buy, with sonelokimab having multiple dermatology and rheumatology indications. MLTX's VELA-1 trial succeeded, and VELA-2's statistical miss was due to elevated placebo response, not drug failure; combined analysis remains highly significant. Regulatory precedent, a strong financial runway into 2027, and multiple upcoming catalysts support a compelling asymmetric risk-reward profile for MLTX.

FRANKFURT, Germany--(BUSINESS WIRE)-- #BINSponsoring--Beyond by RS2, the innovation brand of RS2 Financial Services GmbH, has become a Principal Issuing Member of Visa in Europe – allowing the company to directly issue Visa cards and to launch and manage payment card programs. With this milestone, Beyond by RS2 strengthens its position as an end-to-end payment partner, combining issuing, acquiring, and processing services within a regulated framework to support banks, fintechs, corporates, and merchants in deve.

Soluna Holdings is rated a BUY, leveraging surplus renewable energy for modular data centers and pivoting toward AI and high-performance compute clients. SLNH has maintained gross margins around 25% and secured $35M in new funding for Texas data center expansions. The company is diversifying away from crypto mining, focusing on AI-driven data center hosting, with Project Dorothy 2 and Project Kati as key growth catalysts.

DULUTH, Ga.--(BUSINESS WIRE)--The road to financial recovery may be long, but middle-income families are proving resilient as they adapt to higher costs and redefine their financial goals, according to a new special report from Primerica, Inc. (NYSE: PRI), a leading provider of financial products and services to middle-income families. Titled “The Inflation Hangover: Middle-Income Americans Build Resilience on the Long Road to Recovery,” the report offers an in-depth look at how middle-income h.

Paladin Energy Ltd (OTCQX:PALAF) Shareholder/Analyst Call November 17, 2025 8:00 PM EST Company Participants Mark Lawrenson Paul Hemburrow - MD, CEO & Director Anne Templeman-Jones Michele Buchignani Alexander Rybak - Chief Commercial Officer Presentation Mark Lawrenson Ladies and gentlemen, we can start the meeting. My name is Cliff Lawrenson, and I'm the Chair of the Board of Paladin Energy.

Meta's advertising business remains incredibly strong, with improving engagement metrics and ad prices along with accelerating adoption of AI tools like Advantage+. The firm is currently in the middle of a very heavy CapEx cycle that will pressure margins over the near term but will likely improve sales in the future. The pros appear to vastly outweigh the cons for Meta, and my DCF model indicates the stock is significantly undervalued, especially following the recent sell-off.